Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

80
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Ligand Binding Sites02:40

Ligand Binding Sites

11.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TB.

Clinical proteomics·2026
Same author

Deciphering the molecular crosstalk between type 2 diabetes and pancreatic cancer through cross-disease co-expression network analysis.

Biochemistry and biophysics reports·2026
Same author

A Multi-Omics Study Reveals Pathway-Level Insights and Predictive Biomarkers in pediatric TB.

medRxiv : the preprint server for health sciences·2026
Same author

Plasma multiomics distinguishes pulmonary tuberculosis from other respiratory infections.

medRxiv : the preprint server for health sciences·2026
Same author

Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children: a retrospective cross-sectional study.

Scientific reports·2026
Same author

SynergyGraph: predicting cell line specific drug combination synergy scores using knowledge graph representation and hypergraph modeling.

Scientific reports·2025

Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K

Drug-target interaction prediction via chemogenomic space: learning-based methods.

Zaynab Mousavian1, Ali Masoudi-Nejad

  • 1University of Tehran, Institute of Biochemistry and Biophysics, Laboratory of Systems Biology and Bioinformatics (LBB) , Tehran , Iran +98 21 6695 9256 ; +98 21 6640 4680 ; amasoudin@ibb.ut.ac.ir.

Expert Opinion on Drug Metabolism & Toxicology
|August 13, 2014
PubMed
Summary

Computational methods accelerate drug discovery by predicting drug-target interactions. This review focuses on learning-based approaches, highlighting their potential and limitations in identifying new drug-target pairs.

Keywords:
chemogenomicdrug-targetdrug-target interactionmachine learning

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K

Related Experiment Videos

Last Updated: Apr 26, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K

Area of Science:

  • Genomic drug discovery
  • Computational biology
  • Pharmacology

Background:

  • Identifying drug-target interactions is vital for genomic drug discovery.
  • In silico prediction offers a cost-effective alternative to experimental methods.
  • Computational approaches enable novel drug-target pair analysis.

Purpose of the Study:

  • To review chemogenomic methods for predicting drug-target interactions.
  • To categorize learning-based prediction frameworks.
  • To examine supervised learning approaches in detail.

Main Methods:

  • Focus on chemogenomic methods.
  • Classification of learning-based methods into supervised and semi-supervised.
  • Detailed study of supervised methods: similarity-based and feature-based.

Main Results:

  • Learning-based methods provide a framework for drug-target interaction prediction.
  • Supervised learning encompasses similarity and feature-based techniques.
  • These methods contribute to advancements in pharmacology.

Conclusions:

  • Learning-based methods have improved drug-target interaction prediction.
  • Oversimplification in predictive models can lead to overly optimistic results.
  • Further refinement of computational models is necessary for accurate predictions.